Pediatric reference intervals for lipids and apolipoproteins on the VITROS 5,1 FS Chemistry System

被引:37
作者
Yip, Paul M.
Chan, Man Khun
Nelken, Joanna
Lepage, Nathalle
Brotea, George
Adeli, Khosrow
机构
[1] Hosp Sick Children, Dept Paediat Lab Med, Div Clin Biochem, Toronto, ON M5G 1X8, Canada
[2] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON M5G 1L5, Canada
[3] Childrens Hosp Eastern Ontario, Div Biochem, Ottawa, ON K1H 8L1, Canada
[4] Orthoclin Diagnost, Rochester, NY USA
关键词
pediatric chemistry; newborns; adolescents; cholesterol; triglycerides; HDL cholesterol; LDL cholesterol; apolipoprotein; cardiovascular risk factor; metabolic syndrome;
D O I
10.1016/j.clinbiochem.2006.06.012
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Objectives: Lipid biomarkers are integral in the assessment of dyslipidemia and cardiovascular risk, conditions that have become increasingly prevalent in pediatric populations. A comprehensive set of pediatric reference intervals for traditional or recently established lipid analytes is not currently available. Design and methods: 525 outpatient samples from a pediatric population were categorized into five age groups ranging from 0 to 20 years of age. Groups were further partitioned by gender. Serum or plasma samples were analyzed on the VITROS 5,1 FS Chemistry System for cholesterol and triglycerides by dry-film methods, direct HDL-C and LDL-C by selective detergent elimination, and apolipoproteins AT and B by immunoturbidimetry. Reference intervals were established by non-parametric methods at the 2.5th and 97.5th percentiles. Results: Lipid levels show age- and gender-related differences, particularly during the first year of life and in young adults following puberty. Concentrations of total cholesterol, LDL-C, and apo B were lowest in the 12 months after birth and remained relatively constant throughout childhood, but decreased for males in early adulthood. Triglyceride levels increased gradually throughout childhood and adolescence, and along with cholesterol, the upper limits of these intervals exceeded the recommended concentrations of lipid levels in children. For HDL-C and apo AT, no age- or sex-related differences were found until after puberty when values for males decreased slightly. Conclusions: Our current reference intervals in children and adolescents provide an important update for lipid markers and suggest earlier incidence of hypercholesterolemia when compared to previous ranges. Increased profiling of lipids is anticipated, and these will aid in the early assessment of cardiovascular risk in pediatric populations. (c) 2006 The Canadian Society of Clinical Chemists. All rights reserved.
引用
收藏
页码:978 / 983
页数:6
相关论文
共 39 条
[1]  
*AM AC PED, 1992, PEDIATRICS, V89, P525
[2]  
Bachorik PS, 1997, CLIN CHEM, V43, P2364
[3]  
BACHORIK PS, 1995, CLIN CHEM, V41, P1414
[4]   Serum apolipoprotein A1, B, CII, CIII, E, and lipoprotein (a) levels in children [J].
Baroni, S ;
Scribano, D ;
Valentini, P ;
Zuppi, C ;
Ranno, O ;
Giardina, B .
CLINICAL BIOCHEMISTRY, 1996, 29 (06) :603-605
[5]   Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults [J].
Berenson, GS ;
Srinivasan, SR ;
Bao, WH ;
Newman, WP ;
Tracy, RE ;
Wattigney, WA .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (23) :1650-1656
[6]  
Caudill SP, 1998, CLIN CHEM, V44, P1650
[7]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[8]  
Cole TG, 2000, HDB LIPOPROTEIN TEST, P207
[9]   Overweight in children and adolescents - Pathophysiology, consequences, prevention, and treatment [J].
Daniels, SR ;
Arnett, DK ;
Eckel, RH ;
Gidding, SS ;
Hayman, LL ;
Kumanyika, S ;
Robinson, TN ;
Scott, BJ ;
St Jeor, S ;
Williams, CL .
CIRCULATION, 2005, 111 (15) :1999-2012
[10]  
Duncan I.W., 1982, PROCEDURE PROPOSED C